Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Wortman, B.G."'
Autor:
Wortman, B.G., Bosse, T., Nout, R.A., Lutgens, L.C.H.W., van der Steen-Banasik, E.M., Westerveld, H., van den Berg, H., Slot, A., De Winter, K.A.J., Verhoeven-Adema, K.W., Smit, V.T.H.B.M., Creutzberg, C.L.
Publikováno v:
In Gynecologic Oncology October 2018 151(1):69-75
Autor:
de Boer, S.M. *, Wortman, B.G., Bosse, T., Powell, M.E., Singh, N., Hollema, H., Wilson, G., Chowdhury, M.N., Mileshkin, L., Pyman, J., Katsaros, D., Carinelli, S., Fyles, A., McLachlin, C.M., Haie-Meder, C., Duvillard, P., Nout, R.A., Verhoeven-Adema, K.W., Putter, H., Creutzberg, C.L., Smit, V.T.H.B.M.
Publikováno v:
In Annals of Oncology February 2018 29(2):424-430
Autor:
Horeweg, N., Nout, R.A., Jobsen, J.J., Lutgens, J.C., Jürgenliemk-Schulz, I.M., Haverkort, D.M., Mens, J.W.M., de Jong, M.A., Wortman, B.G., de Boer, S.M., Putter, H., Stelloo, E., Smit, V.T., Bosse, T., Creutzberg, C.L.
Publikováno v:
In Radiotherapy and Oncology May 2023 182 Supplement 1:S415-S417
Autor:
Wortman, B.G.
Publikováno v:
None
Endometrial cancer (EC) is the most common gynaecological cancer in developed countries. Standard treatment consists of surgery (hysterectomy and bilateral salpingo-oophorectomy) followed by either no adjuvant treatment, vaginal brachytherapy (VBT) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::19b0dabf936d4af5a10cbc1d701b6bb0
https://hdl.handle.net/1887/3492091
https://hdl.handle.net/1887/3492091
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wortman, B.G., Astreinidou, E., Laman, M.S., Steen-Banasik, E.M. van der, Lutgens, L.C.H.W., Westerveld, H., Koppe, F., Slot, A., Berg, H.A. van den, Nowee, M.E., Bijmolt, S., Stam, T.C., Zwanenburg, A.G., Mens, J.W.M., Jurgenliemk-Schulz, I.M., Snyers, A., Gillham, C.M., Weidner, N., Kommoss, S., Vandecasteele, K., Tomancova, V., Creutzberg, C.L., Nout, R.A., PORTEC Study Grp
Publikováno v:
Radiotherapy and Oncology, 155, 160-166. Elsevier {BV}
Radiotherapy and Oncology, 155, 160-166. Elsevier Ireland Ltd
Radiotherapy and Oncology, 155, pp. 160-166
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 155, 160-166. Elsevier
Radiotherapy and Oncology, 155, 160-166
RADIOTHERAPY AND ONCOLOGY
Radiotherapy and Oncology, 155, 160-166. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 155, 160-166. Elsevier Ireland Ltd
Radiotherapy and Oncology, 155, 160-166. Elsevier Ireland Ltd
Radiotherapy and Oncology, 155, pp. 160-166
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 155, 160-166. Elsevier
Radiotherapy and Oncology, 155, 160-166
RADIOTHERAPY AND ONCOLOGY
Radiotherapy and Oncology, 155, 160-166. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 155, 160-166. Elsevier Ireland Ltd
Contains fulltext : 229838.pdf (Publisher’s version ) (Open Access) OBJECTIVE: The PORTEC-4a trial investigates molecular-integrated risk profile guided adjuvant treatment for endometrial cancer. The quality assurance programme included a dummy run
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2893ea5a0941a7ee3d48687f74736d1
https://hdl.handle.net/1887/3280417
https://hdl.handle.net/1887/3280417
Autor:
Wortman, B.G., Creutzberg, C.L., Putter, H., Jurgenliemk-Schulz, I.M., Jobsen, J.J., Lutgens, L.C.H.W., Steen-Banasik, E.M. van der, Mens, J.W.M., Slot, A., Kroese, M.C.S., Triest, B. van, Nijman, H.W., Stelloo, E., Bosse, T., Boer, S.M. de, Putten, W.L.J. van, Smit, V.T.H.B.M., Nout, R.A., PORTEC Study Grp
Publikováno v:
British Journal of Cancer, 119(9), 1067-1074
British Journal of Cancer
British Journal of Cancer, 119(9), 1067-1074. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 119(9), 1067-1074. Nature Publishing Group
BACKGROUND: PORTEC-2 was a randomised trial for women with high-intermediate risk (HIR) endometrial cancer, comparing pelvic external beam radiotherapy (EBRT) with vaginal brachytherapy (VBT). We evaluated long-term outcomes combined with the results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4323ee51d7efa4e63c525cf8f65e972
https://hdl.handle.net/1887/86376
https://hdl.handle.net/1887/86376
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Boer, S.M. de, Wortman, B.G., Bosse, T., Powell, M.E., Singh, N., Hollema, H., Wilson, G., Chowdhury, M.N., Mileshkin, L., Pyman, J., Katsaros, D., Carinelli, S., Fyles, A., McLachlin, C.M., Haie-Meder, C., Duvillard, P., Nout, R.A., Verhoeven-Adema, K.W., Putter, H., Creutzberg, C.L., Smit, V.T.H.B.M., PORTEC Study Grp
Publikováno v:
Annals of Oncology, 29(2), 424-430
Annals of Oncology, 424-430
STARTPAGE=424;ENDPAGE=430;TITLE=Annals of Oncology
Annals of Oncology
Annals of Oncology, 29(2), 424-430. Oxford University Press
Annals of Oncology, 424-430
STARTPAGE=424;ENDPAGE=430;TITLE=Annals of Oncology
Annals of Oncology
Annals of Oncology, 29(2), 424-430. Oxford University Press
Background: In the PORTEC-3 trial, women with high-risk endometrial cancer (HR-EC) were randomised to receive pelvic radiotherapy (RT) with or without concurrent and adjuvant chemotherapy (two cycles of cisplatin 50 mg/m2 in weeks 1 and 4 of RT, foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc18ba38471d07b4e3ce0f37c0d670c1
http://hdl.handle.net/1887/75048
http://hdl.handle.net/1887/75048
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.